Anaplastic Lymphoma Kinase Positive Mesenteric Inflammatory Myofibroblastic Tumor in Adult Woman
Open Access
- 23 April 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24422
Abstract
Inflammatory myofibroblastic tumors (IMTs) are rare mesenchymal neoplasms containing spindle cells and inflammatory components that can be locally aggressive. They have unclear biological behavior and may recur after resection. A 31-year-old woman presented with three months of cough, fatigue, weight loss, abdominal pain, anemia, and elevated inflammatory markers. CT showed a large well-circumscribed enhancing mass in the right colic mesentery. The patient underwent a laparoscopic right colectomy. Pathologic review showed fascicular spindle cells with admixed chronic inflammatory cells. Cells stained diffusely positive for SMA and anaplastic lymphoma kinase (ALK), diagnostic of an IMT. Post-operatively, the patient reported symptom resolution and had normalization of lab values. She remains disease-free at 20 months. IMT is rare in adults, accounting for 0.7%-1.0% of lung tumors. Up to 30% of patients present with elevated inflammatory markers. On imaging, IMTs are soft tissue masses with variable enhancement and fibrosis, often suspected to be malignant neoplasms. Up to 80% of IMTs are driven by altered tyrosine kinase signaling and half of IMTs express ALK, which may be treated in unresectable/recurrent cases using ALK-inhibitors. IMT may recur in 10%-15% of patients. The roles of adjuvant treatments are unclear given the rarity and unpredictable biological behavior. Long-term follow-up with regular radiologic and laboratory surveillance is recommended given possible local recurrence. IMTs are best managed in a multidisciplinary setting given their unpredictable nature. Surgery is the mainstay of IMT treatment with long-term control expected in >80% of adult patients.Keywords
This publication has 18 references indexed in Scilit:
- Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase FusionsCancer Discovery, 2014
- Inflammatory Pseudotumor: The Great MimickerAmerican Journal of Roentgenology, 2012
- Inflammatory myofibroblastic tumours: where are we now?Journal of Clinical Pathology, 2007
- Inflammatory myofibroblastic tumorsJournal of Surgical Oncology, 2006
- Inflammatory PseudotumorRadioGraphics, 2003
- Expression of ALK1 and p80 in Inflammatory Myofibroblastic Tumor and Its Mesenchymal Mimics: A Study of 135 CasesLaboratory Investigation, 2002
- ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic TumorLaboratory Investigation, 2001
- Extrapulmonary Inflammatory Myofibroblastic Tumor (Inflammatory Pseudotumor) A Clinicopathologic and Immunohistochemical Study of 84 CasesAmerican Journal of Surgical Pathology, 1995
- Abdominal inflammatory myofibroblastic tumours in childrenBritish Journal of Surgery, 1992
- Inflammatory pseudotumor of the lung in adults: Radiographic and clinicopathological analysisThe Annals of Thoracic Surgery, 1989